Mesa Laboratories, Inc. (MLAB)

NASDAQ: MLAB · IEX Real-Time Price · USD
90.37
+5.00 (5.86%)
Dec 1, 2023, 4:00 PM EST - Market closed
5.86%
Market Cap 487.25M
Revenue (ttm) 213.69M
Net Income (ttm) -717,000
Shares Out 5.39M
EPS (ttm) -0.14
PE Ratio n/a
Forward PE 69.76
Dividend $0.64 (0.71%)
Ex-Dividend Date Nov 29, 2023
Volume 46,008
Open 84.66
Previous Close 85.37
Day's Range 84.66 - 91.13
52-Week Range 82.86 - 206.36
Beta 0.83
Analysts n/a
Price Target n/a
Earnings Date Nov 6, 2023

About MLAB

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to per... [Read more]

Sector Technology
Founded 1982
Employees 698
Stock Exchange NASDAQ
Ticker Symbol MLAB
Full Company Profile

Financial Performance

In 2022, MLAB's revenue was $219.08 million, an increase of 18.85% compared to the previous year's $184.34 million. Earnings were $930,000, a decrease of -50.29%.

Financial Statements

News

Mesa Labs Announces Second Quarter Results

LAKEWOOD, Colo., Nov. 06, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, ...

27 days ago - GlobeNewsWire

Mesa Labs Acquires GKE-GmbH Complementary Sterilization Indicators and Healthcare Channels to Mesa's SDC Platform

Lakewood, Colo., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us” or “our”), a global leader in the design and manufacturing of life science tools and critic...

7 weeks ago - GlobeNewsWire

MESA LABS DECLARES QUARTERLY DIVIDEND

LAKEWOOD, Colo., Oct. 03, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quart...

2 months ago - GlobeNewsWire

Mesa Laboratories, Inc. to Announce Second Quarter Results on November 6, 2023

LAKEWOOD, Colo., Sept. 13, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the second quarter of fiscal year 2024 at approximately ...

2 months ago - GlobeNewsWire

Mesa Laboratories, Inc. Announces Commitment to Disclose Scope 1 and 2 Greenhouse Gas Emissions

LAKEWOOD, Colo., Aug. 24, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories Inc (Nasdaq: MLAB; “Mesa” or the “Company”), a global leader in the design and manufacturing of life science tools and critical qua...

3 months ago - GlobeNewsWire

Mesa Labs Announces First Quarter Results

LAKEWOOD, Colo., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, ...

4 months ago - GlobeNewsWire

Mesa Laboratories, Inc. to Announce First Quarter Results on August 3, 2023

LAKEWOOD, Colo., June 21, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the first quarter of fiscal year 2024 at approximately 8:...

5 months ago - GlobeNewsWire

Mesa Labs Announces Unaudited Fourth Quarter and Full Fiscal Year 2023 Results

LAKEWOOD, Colo., May 25, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, t...

6 months ago - GlobeNewsWire

Mesa Labs Announces Third Quarter Results

LAKEWOOD, Colo., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacturing of life science tools and critical quality control solutions, ...

10 months ago - GlobeNewsWire

Mesa Labs Declares Quarterly Dividend

LAKEWOOD, Colo., Jan. 03, 2023 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quart...

11 months ago - GlobeNewsWire

Mesa Laboratories, Inc. to Announce Third Quarter Results on February 6, 2023

LAKEWOOD, Colo., Dec. 16, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) will issue a press release with financial results for the third quarter of fiscal year 2023 at approximately 8:...

1 year ago - GlobeNewsWire

Mesa Labs Acquires Belyntic's Peptide Purification Business

Lakewood, Colorado, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical quality control...

1 year ago - GlobeNewsWire

Mesa Laboratories, Inc. Appoints Shiraz Ladiwala as Lead Independent Director

Appointment is a Key Step in Enhancing Mesa's Corporate Governance Appointment is a Key Step in Enhancing Mesa's Corporate Governance

1 year ago - GlobeNewsWire

Mesa Laboratories Appoints Tony Tripeny to its Board of Directors

LAKEWOOD, Colo., June 27, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) announced the appointment of Tony Tripeny to its Board of Directors (the “Board”), effective June 23, 2022. Ton...

1 year ago - GlobeNewsWire

Mesa Labs Reports Fourth Quarter and Full Fiscal Year Results

LAKEWOOD, Colo., May 31, 2022 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the fourth quarter (“4Q22”) and full year ended March 31, 2022 (“FY22”).

1 year ago - GlobeNewsWire

Mesa Labs Closes Acquisition of Agena Bioscience

LAKEWOOD, Colo., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced that it has completed the previously announced acquisition of Agena Biosciences, Inc. With this...

2 years ago - GlobeNewsWire

Mesa Labs Announces Agreement to Acquire Agena Bioscience, Inc.

LAKEWOOD, Colo., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (“we”, “us”, “our”, “Mesa” or the “Company”), a global leader in the design and manufacturing of critical qual...

2 years ago - GlobeNewsWire

Mesa Laboratories: Q4 Earnings Insights

Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results. Quarterly Results Earnings per share increased 53.49% year over year to $1.98, which beat the estimate o...

2 years ago - Benzinga

Mesa Labs Reports Third Quarter Results for FY21

LAKEWOOD, Colo., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the third quarter (“3Q21”) and nine months ended December 31, 2020.

3 years ago - GlobeNewsWire

Mesa Labs Reports Second Quarter Results for FY21

LAKEWOOD, Colo., Nov. 05, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the second quarter (“2Q21”) and six months ended September 30, 2020.

3 years ago - GlobeNewsWire

Mesa Labs Reports First Quarter Results

LAKEWOOD, Colo., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) today announced results for the first quarter (“1Q21”).

3 years ago - GlobeNewsWire

Mesa Laboratories, Inc. Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares of Common Stock in Public Offering

Source:  Mesa Laboratories, Inc. – June 16, 2020 11:30 AM ET

3 years ago - GlobeNewsWire

Mesa Laboratories, Inc. Announces Upsizing and Pricing of Public Offering of Common Stock

Source: Mesa Laboratories, Inc. - June 9, 2020 8:15 PM ET

3 years ago - GlobeNewsWire

Mesa Laboratories, Inc. Announces Proposed Public Offering of Common Stock

Source: Mesa Laboratories, Inc. – June 8, 2020 4:01 PM ET

3 years ago - GlobeNewsWire

Recap: Mesa Laboratories Q4 Earnings

Shares of Mesa Laboratories (NASDAQ:MLAB) were unchanged after the company reported Q4 results.

3 years ago - Benzinga